Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Morano

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Human Immunology|October 20, 1999
Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitusS Morano, C Tiberti, G Cristina, et al.
Diabetes Care|June 1, 1988
Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic controlG Pozzessere, P A Rizzo, E Valle, et al.
Transplantation|December 10, 1999
Effect of islet transplantation on neuroelectrophysiological abnormalities in diabetic inbred Lewis rats: comparison of primary versus secondary preventionM Sensi, S Morano, E Valle, et al.
Nephron. Experimental Nephrology|October 2, 2003
Angiotensin-converting enzyme inhibition modulates high-glucose-induced extracellular matrix changes in mouse glomerular epithelial cellsS Morano, R Cipriani, M G Cerrito, et al.
Archives of Gerontology and Geriatrics|January 1, 1992
Enhanced nonenzymatic glycation of eye lens proteins in experimental diabetes mellitus: an approach for the study of protein alterations as mediators of normal aging phenomenaM Sensi, F Pricci, C Pugliese, et al.
Journal of Endocrinological Investigation|June 27, 2016
Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatinC Santangelo, C Filesi, R Varì, et al.
La Clinica Terapeutica|June 15, 2010
[Diagnosing silent cardiac dysautonomia via ambulatory blood pressure monitoring: early diagnosis shown by the lack of heart rate circadian rhythm in type 1 diabetes mellitus]P Cugini, S Amato, G Tarquini, et al.
Transplantation|October 31, 2001
Advanced glycation end product levels in eye lenses, aorta, and tail tendon in transplanted diabetic inbred Lewis ratsM Sensi, S Morano, E Sagratella, et al.
Journal of Endocrinological Investigation|November 12, 2018
The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidenceS Giannattasio, C Corinaldesi, M Colletti, et al.
Diabetes Research and Clinical Practice|April 1, 1995
Role of advanced glycation end-products (AGE) in late diabetic complicationsM Sensi, F Pricci, G Pugliese, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Human Immunology|October 20, 1999
Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitusS Morano, C Tiberti, G Cristina, et al.
Diabetes Care|June 1, 1988
Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic controlG Pozzessere, P A Rizzo, E Valle, et al.
Transplantation|December 10, 1999
Effect of islet transplantation on neuroelectrophysiological abnormalities in diabetic inbred Lewis rats: comparison of primary versus secondary preventionM Sensi, S Morano, E Valle, et al.
Nephron. Experimental Nephrology|October 2, 2003
Angiotensin-converting enzyme inhibition modulates high-glucose-induced extracellular matrix changes in mouse glomerular epithelial cellsS Morano, R Cipriani, M G Cerrito, et al.
Archives of Gerontology and Geriatrics|January 1, 1992
Enhanced nonenzymatic glycation of eye lens proteins in experimental diabetes mellitus: an approach for the study of protein alterations as mediators of normal aging phenomenaM Sensi, F Pricci, C Pugliese, et al.
Journal of Endocrinological Investigation|June 27, 2016
Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatinC Santangelo, C Filesi, R Varì, et al.
La Clinica Terapeutica|June 15, 2010
[Diagnosing silent cardiac dysautonomia via ambulatory blood pressure monitoring: early diagnosis shown by the lack of heart rate circadian rhythm in type 1 diabetes mellitus]P Cugini, S Amato, G Tarquini, et al.
Transplantation|October 31, 2001
Advanced glycation end product levels in eye lenses, aorta, and tail tendon in transplanted diabetic inbred Lewis ratsM Sensi, S Morano, E Sagratella, et al.
Journal of Endocrinological Investigation|November 12, 2018
The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidenceS Giannattasio, C Corinaldesi, M Colletti, et al.
Diabetes Research and Clinical Practice|April 1, 1995
Role of advanced glycation end-products (AGE) in late diabetic complicationsM Sensi, F Pricci, G Pugliese, et al.
Pageof 7